{"disease":{"id":"pityriasis-versicolor","name":"Pityriasis versicolor","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":12,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"levomenthol","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salonpas","generic_name":"LEVOMENTHOL","company_name":"","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily M member 8","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"clotrimazole","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"sulconazole","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelderm","generic_name":"SULCONAZOLE","company_name":"Journey","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19","drug_class":"Azole Antifungal","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"acrisorcin","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Akrinol","generic_name":"ACRISORCIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"butenafine","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mentax","generic_name":"BUTENAFINE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Benzylamine Antifungal","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"omoconazole","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OMOCONAZOLE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"omoconazole","quality_score":null,"revenue":null,"mechanism":"Omoconazole works by inhibiting the growth of fungal cells."},{"drug_id":"econazole","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spectazole","generic_name":"ECONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Thromboxane-A synthase","drug_class":"Azole Antifungal","quality_score":48,"revenue":null,"mechanism":"Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes."},{"drug_id":"miconazole","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ketoconazole","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nizoral","generic_name":"ketoconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1","drug_class":"Azole Antifungal [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"selenium-sulfide","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selsun","generic_name":"SELENIUM SULFIDE","company_name":"Chattem","drug_phase":"marketed","molecular_target":"","drug_class":"selenium sulfide","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"ciclopirox","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loprox","generic_name":"CICLOPIROX","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Poly [ADP-ribose] polymerase 1","drug_class":"ciclopirox","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"penlac","indication_name":"Pityriasis versicolor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Penlac","company_name":"9305-9954 Quebec Inc","drug_phase":"phase_2","molecular_target":"Deoxyhypusine hydroxylase, Poly [ADP-ribose] polymerase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":12,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05067699","title":"Vitamin D Level in Recurrent PV","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT04769804","title":"Gene Polymorphism in Tinea Versicolor","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT06922344","title":"Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":106,"lead_sponsor_name":"Khyber Teaching Hospital","has_results":false},{"nct_id":"NCT04007237","title":"The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT07331792","title":"Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":86,"lead_sponsor_name":"Combined Military Hospital Abbottabad","has_results":false},{"nct_id":"NCT06170333","title":"8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Universitas Padjadjaran","has_results":false},{"nct_id":"NCT05730244","title":"A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"The University of The West Indies","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}